Pulmonary arterial hypertension is a rare disease often associated with positive antinuclear
antibody and high mortality. Pulmonary hypertension, which rarely is severe, occurs …

Pulmonary hypertension is defined as a mean pulmonary artery pressure≥ 25 mm Hg and
is a recently recognized complication of chronic kidney disease and end-stage renal …

Current classifications of pulmonary hypertension have contributed a great deal to our
understanding of pulmonary vascular disease, facilitated drug trials, and improved our …

Background The prevalence, determinants and prognosis of pulmonary hypertension
among long-term hemodialysis patients in the USA are poorly understood. Methods A cross …

Pulmonary hypertension (PH) is common in patients with dialysis-dependent chronic kidney
disease and is an independent predictor of mortality. However, specific hemodynamics of …

Pulmonary hypertension (PH) is associated with poor outcomes in the dialysis and general
populations, but its effect in CKD is unclear. We evaluated the prevalence and predictors of …

Background Pulmonary hypertension (PH), a disease which carries substantial morbidity
and mortality, has been reported to occur in 25%–45% of dialysis patients. No prospective …

Cardiovascular disease is the leading cause of the death in dialysis patients. Arteriovenous
fistulas (AVFs) are associated with lower mortality and are viewed as the desired access …

Pulmonary hypertension (PH) is highly prevalent in end-stage renal disease. Several
observational studies, based on an echocardiographic diagnosis of PH, have suggested a …

Abstract Background/Aims: Pulmonary hypertension (PHT) has been reported to be high
among end-stage renal disease (ESRD) patients. This study evaluated PHT in ESRD …